Previous 10 | Next 10 |
2023-05-19 06:00:00 ET 3 Tips for Shifting Your Mindset When Swing Trading Penny Stocks Navigating the world of penny stocks calls for a distinct blend of market knowledge, discernment, and resilience. Penny stocks , often associated with small-scale enterprises, offer attractive gr...
2023-05-18 18:38:14 ET Gainers: Farfetch Limited ( FTCH ) +18% . Ouster ( OUST ) +9%. Guardforce AI ( GFAI ) +4% . GSI Technology ( GSIT ) +4%. Losers: CaliberCos ( CWD ) -9%. Flowers Foods ( FLO ) -5%. DXC Te...
2023-05-18 10:04:28 ET Gainers: Enveric Biosciences ( ENVB ) +68% . Alimera Sciences ( ALIM ) +35% . Corvus Pharmaceuticals ( CRVS ) +12% . Viracta Therapeutics ( VIRX ) +11% . Bullfrog AI Holdings ( BFRG ) +8% . Losers: N...
2023-05-18 07:49:20 ET Nano-cap pharma Alimera Sciences ( NASDAQ: ALIM ) added ~48% pre-market Thursday after announcing the acquisition of U.S. commercial rights for eye disorder therapy Yutiq from EyePoint Pharmaceuticals ( NASDAQ: EYPT ). The treatment, also known...
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023 Alimera projects at least $100 million of consolidated net revenue and over $20 million of Adjusted EBITDA* in 2024 Leverages Alimera’s existing U.S. commercial infrastructure In...
ATLANTA, May 17, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will host i...
2023-05-15 07:54:51 ET Alimera Sciences press release ( NASDAQ: ALIM ): Q1 GAAP EPS of -$0.71 misses by $0.19 . Revenue of $13.55M (+14.0% Y/Y) beats by $1.25M . For further details see: Alimera Sciences GAAP EPS of -$0.71 misses by $0.19, revenue of $13....
Consolidated Net Revenue of $13.5 Million Up 14% vs. First Quarter of 2022 Global End User Demand Up 14% vs. First Quarter of 2022 Financial Results and Corporate Update Conference Call Cancelled ATLANTA, May 15, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. ...
2023-05-12 10:44:38 ET Major earnings expected before the bell on Monday include: Adamis Pharmaceuticals ( ADMP ) CV Sciences ( OTCQB:CVSI ) Sundial Growers ( SNDL ) Sunworks ( SUNW ) Workhorse Group ( WKHS ) For further details see: Notab...
ATLANTA, May 08, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will report...
News, Short Squeeze, Breakout and More Instantly...
Alimera Sciences Inc. Company Name:
ALIM Stock Symbol:
NASDAQ Market:
Alimera Sciences Inc. Website:
2024-07-07 16:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-25 11:30:02 ET Alliance Global Partners analyst issues NEUTRAL recommendation for ALIM on June 25, 2024 10:23AM ET. The previous analyst recommendation was Buy. ALIM was trading at $5.53 at issue of the analyst recommendation. The overall analyst consensus : HOLD...
2024-06-25 07:00:05 ET Yi Chen from H.C. Wainwright issued a price target of $6.00 for ALIM on 2024-06-25 06:08:00. The adjusted price target was set to $6.00. At the time of the announcement, ALIM was trading at $5.54. The overall price target consensus is at $7.25 with...